Precision therapeutics for the precision medicine era

Adam Gregory

Adam Gregory
17 May 2019

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.

Personalised medicine: patient stratification

Simon Kiddle

Simon Kiddle
29 Apr 2019

While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.

Pioneers of precision medicine

Frances Salisbury

Frances Salisbury
15 Apr 2019

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is leading.

Hydrogen: the storage question

Matthew Smith

Matthew Smith
04 Apr 2019

There’s a lot to like about hydrogen.  It’s light; it’s abundant (at least atomically - water and hydrocarbons contain plenty of hydrogen atoms); it’s.

Building an effective drug franchise: A Transatlantic perspective  -  April 23, Boston, MA

Jacqueline Murphy

Jacqueline Murphy
02 Apr 2019

It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your discoveries . In.

The road to autonomous

Christoph Moeller

Christoph Moeller
28 Mar 2019

In a recent article published in Intellectual Property Magazine, Christoph Moeller explores the data issues surrounding future mobility. 

Dosage regimen patents: bruised but not beaten

Julie Carlisle

Julie Carlisle
28 Mar 2019

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.

Playing for time: strategies that can help extend a drug's patent life

Emily Hayes

Emily Hayes
25 Mar 2019

In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC.  Hunter explores a typical drug development timeline and suggests.

Former CITMA President Kate O’Rourke to head our European trade mark services

Maria Hall

Maria Hall
11 Mar 2019

We are delighted to announce that Kate O’Rourke will join the firm on 1 April 2019.   

Can the EPO hold oral proceedings in Haar without infringing a party’s right to be heard?  A new referral to the Enlarged Board raises this question.

Sean Constable

Sean Constable
06 Mar 2019

The right to be heard under Article 113(1) EPC requires that parties involved in proceedings before the EPO have the right to present their arguments at.

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

Frances Salisbury

Frances Salisbury
27 Feb 2019

We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.

How to patent AI technology at the EPO

Emma Graham

Emma Graham
26 Feb 2019

Once only a figment of the imagination in literature such as Mark Shelley’s Frankenstein, artificial intelligence, commonly known as AI, is now realised.

Self-driving vehicles: what do consumers think (and want)?

Christoph Moeller

Christoph Moeller
25 Feb 2019

As a survey of 25,000 consumers in 20 countries, and a study that has been conducted annually over the past ten years, the Deloitte Global Automotive.

Is your interest legitimate? New referral to the EBOA on double patenting

Simon Kiddle

Simon Kiddle
22 Feb 2019

EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal.  The answers may force.

Building an IP portfolio: Nine tips for success

Matthew Smith

Matthew Smith
15 Feb 2019

Companies need to think carefully about how they protect, manage and leverage the various intellectual property (IP) assets across their business..

Plant related inventions: clarity at last?

Andrew Tindall

Andrew Tindall
06 Feb 2019

As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial prohibition at the EPO against the grant of patents for.

Fighting cancer with CAR-T therapies

Frances Salisbury

Frances Salisbury
04 Feb 2019

In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, Kymriah, to children with advanced leukaemia. This was.

Commercialising genomic research in the US: tips for obtaining patent protection

Emily Hayes

Emily Hayes
30 Jan 2019

The field of genomics has seen incredible advances over the past few decades. Technological developments coupled with decreasing costs have fuelled this.

China - a key player in the global precision medicine race

Frances Salisbury

Frances Salisbury
30 Jan 2019

With a growing economy, and a large, ageing population, China is attracting attention from global pharmaceutical and biotechnology companies. China’s home.

Autonomous driving: the IP twists and turns

Christoph Moeller

Christoph Moeller
28 Jan 2019

Autonomous driving (AD) is on everyone’s lips when it comes to the next big thing in the automotive industry, especially as it is nowadays regularly.